Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers

CompletedOBSERVATIONAL
Enrollment

62

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Influenza, HumanSmokingRespiratory Tract InfectionsHabits
Interventions
BIOLOGICAL

LAIV

Standard dose of LAIV administered by a licensed health care providers.

Trial Locations (1)

27599

Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

Food and Drug Administration (FDA)

FED

collaborator

Tobacco Centers of Regulatory Science (TCORS

UNKNOWN

lead

University of North Carolina, Chapel Hill

OTHER

NCT02019745 - Effects of Tobacco Products on Live Attenuated Influenza Virus (LAIV) Infections in Human Volunteers | Biotech Hunter | Biotech Hunter